Highlights Sol-Gel Technologies Ltd.

Equities

SLGL

IL0011417206

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-01 pm EDT			5-day change	1st Jan Change
0.782 ^USD	+9.75%		-15.48%	-29.23%

Mar. 13	Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 29	Sol-Gel Technologies Ltd. Elects Yuval Yanai as External Director	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
Sol-Gel Technologies Ltd. Screens First Patient for SGT-610 Phase 3 Study	Nov. 30	CI
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Sol-Gel Technologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Sol-Gel Technologies, Searchlight Pharma Sign Licensing Deals for 2 Dermatology Drugs	23-06-06	MT
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO and EPSOLAY in Canada	23-06-06	CI
Sol-Gel Technologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-10	CI
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-10	CI
Sol Gel Technologies : NOTICE OF SPECIAL MEETING OF SHAREHOLDERS - Form 6-K	23-03-01	PU
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Sol-Gel Technologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04	CI
Sol-Gel Technologies Announces FDA Approval of EPSOLAY	22-04-25	CI
Sol-Gel Grants Galderma Holding SA the Exclusive Rights to Commercialize EPSOLAY in the United States	22-04-25	CI
Sol-Gel Technologies Announces the Commercial Availability of TWYNEO	22-04-14	CI
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Sol-Gel Technologies Says US FDA to Inspect its Epsolay Production Site in February	21-12-21	MT
Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®	21-12-21	CI
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Sol-Gel Technologies Ltd. Announces New Agreement with Padagis	21-11-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sol-Gel Technologies Ltd.

Equities

SLGL

IL0011417206

Highlights

Filters